<bill session="117" type="s" number="3080" updated="2022-12-30T07:48:45Z">
  <state datetime="2021-10-27">REFERRED</state>
  <status>
    <introduced datetime="2021-10-27"/>
  </status>
  <introduced datetime="2021-10-27"/>
  <titles>
    <title type="display">Cancer Drug Parity Act of 2021</title>
    <title type="short" as="introduced">Cancer Drug Parity Act of 2021</title>
    <title type="official" as="introduced">A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.</title>
  </titles>
  <sponsor bioguide_id="S001203"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2021-10-27"/>
    <cosponsor bioguide_id="B001277" joined="2021-10-27"/>
    <cosponsor bioguide_id="B001236" joined="2021-10-27"/>
    <cosponsor bioguide_id="B000944" joined="2021-10-27"/>
    <cosponsor bioguide_id="C001047" joined="2021-10-27"/>
    <cosponsor bioguide_id="C001035" joined="2021-10-27"/>
    <cosponsor bioguide_id="C001096" joined="2021-10-27"/>
    <cosponsor bioguide_id="F000062" joined="2021-12-09"/>
    <cosponsor bioguide_id="H001079" joined="2021-10-27"/>
    <cosponsor bioguide_id="K000383" joined="2022-09-29"/>
    <cosponsor bioguide_id="K000367" joined="2021-10-27"/>
    <cosponsor bioguide_id="M000133" joined="2021-10-27"/>
    <cosponsor bioguide_id="M001176" joined="2021-10-27"/>
    <cosponsor bioguide_id="M000934" joined="2021-10-27"/>
    <cosponsor bioguide_id="M001153" joined="2021-11-17"/>
    <cosponsor bioguide_id="M001169" joined="2021-10-27"/>
    <cosponsor bioguide_id="R000122" joined="2021-12-17"/>
    <cosponsor bioguide_id="S001217" joined="2021-10-27"/>
    <cosponsor bioguide_id="T000464" joined="2022-04-26"/>
    <cosponsor bioguide_id="W000802" joined="2021-10-27"/>
    <cosponsor bioguide_id="W000437" joined="2021-10-27"/>
  </cosponsors>
  <actions>
    <action datetime="2021-10-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-10-27" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="4385" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-02-13T16:18:25Z" status="Introduced in Senate">Cancer Drug Parity Act of 2021

This bill requires group health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, plans may not,&#160;with respect to&#160;anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.</summary>
</bill>
